Ana Lita

About Ana Lita

This author has not yet filled in any details.
So far Ana Lita has created 226 blog entries.

Understanding Covid-19, a ‘supernova’ in human history

Over the next few decades, economists, epidemiologists, public health experts, historians, philosophers, sociologists, physicians, psychologists, and others will work to untangle the interwoven threads. Even now it takes a village just to answer what seems to be a simple question: How many people have died from Covid-19? Learn more here. Article by Vinay Prasad and [...]

By |2020-05-15T05:21:44+00:00May 15th, 2020|News-Letters|Comments Off on Understanding Covid-19, a ‘supernova’ in human history

Lockdown protesters have a moral duty to forgo medical care in favor of those who followed the rules

Would it be fair if a protestor used a ventilator after contracting COVID-19 from the protests when resources are limited? Learn more here. Article by Dominic Sisti, Moti Gorin, Emily Largent and Arthur Caplan

By |2020-05-12T18:20:33+00:00May 12th, 2020|News-Letters|Comments Off on Lockdown protesters have a moral duty to forgo medical care in favor of those who followed the rules

Doctors lambaste federal process for distributing Covid-19 drug remdesivir

Hospitals and physicians around the country are sharply criticizing the federal government for the uneven and opaque way it is distributing its supply of the Covid-19 drug remdesivir. Learn more here. Article by Eric Boodman and Casey Ross

By |2020-05-08T19:03:19+00:00May 8th, 2020|News-Letters|Comments Off on Doctors lambaste federal process for distributing Covid-19 drug remdesivir

A coronavirus vaccine may be available in record time, but experts predict pandemonium during the rollout

Progress on a coronavirus vaccine is moving at record speed, with some experts predicting widespread availability by spring 2021. But without a solid plan for distribution, bioethicist Arthur Caplan told Business Insider "there will be fights about who gets priority." Learn more here. Article by Sarah Kramer

By |2020-05-06T20:23:18+00:00May 6th, 2020|News-Letters|Comments Off on A coronavirus vaccine may be available in record time, but experts predict pandemonium during the rollout

Profits and Pride at Stake, the Race for a Vaccine Intensifies

Governments, companies and academic labs are accelerating their efforts amid geopolitical crosscurrents, questions about safety and the challenges of producing enough doses for billions of people. Learn more here. Article by David Sanger

By |2020-05-03T17:51:50+00:00May 3rd, 2020|News-Letters|Comments Off on Profits and Pride at Stake, the Race for a Vaccine Intensifies

These scientists saw the coronavirus coming. Now they’re trying to stop the next pandemic before it starts.

Viral threats, like the coronavirus, already exist in animals, so it is a matter of time for when humans encounter animals that are carrying a deadly virus. Epstein and other researchers have been working on preventing a spillover from animals to human populations. Learn more here. Article by Shannon Osaka [...]

By |2020-05-01T03:00:27+00:00May 1st, 2020|News-Letters|Comments Off on These scientists saw the coronavirus coming. Now they’re trying to stop the next pandemic before it starts.

Speculation in the absence of data can be deadly

During the COVID-19 crisis, there has been an explosion of PR claims on treatments and cures for coronavirus. Science is more than speculation and gain. Learn more here. Article by Art Caplan and Kenneth Moch

By |2020-04-30T03:00:16+00:00April 30th, 2020|News-Letters|Comments Off on Speculation in the absence of data can be deadly

FDA warns against widespread use of hydroxychloroquine, drug touted by Trump

The Food and Drug Administration has advised against the use of hydroxychloroquine, though it has been repeatedly touted by Trump as an effective treatment. Learn more here. Article by Matthew Herper

By |2020-04-27T19:49:10+00:00April 27th, 2020|News-Letters|Comments Off on FDA warns against widespread use of hydroxychloroquine, drug touted by Trump